Literature DB >> 12149598

The role of coping with disease in adherence to treatment regimen and disease control in type 1 and insulin treated type 2 diabetes mellitus.

B Turan1, Z Osar, J Molzan Turan, T Damci, H Ilkova.   

Abstract

BACKGROUND: Coping is defined as the behavioral and cognitive efforts used in an attempt to deal with stressful events. The objective of this study was to explore the relationship between coping with diabetes and the following outcome variables in type 1 and insulin treated type 2 diabetes mellitus: glycemic control, microangiopathic complications, adherence to self monitoring of blood glucose, adherence to insulin injections, and adherence to diet.
METHODS: Subjects were 196 insulin treated adult diabetes patients visiting an outpatient clinic at a government university hospital in Istanbul, Turkey. Coping with disease was measured with the Turkish version of the Diabetes Coping Measure and adherence to treatment regimen was measured with a questionnaire adapted from the subscales of the Summary of Diabetes Self-Care Activities Questionnaire. Data on patients' HbA(1c) levels and severity of microangiopathic complications were obtained from their medical records.
RESULTS: Partial correlations controlling for background variables suggested that coping was a good predictor of outcome for both type 1 and insulin treated type 2 diabetes mellitus. These associations were more pronounced for type 1 patients when compared to type 2 patients. Regressing the outcome variables on the two second-order coping factors (obtained by a factor analysis) also supported the hypothesis that coping is an important construct in explaining the outcome variables. Finally, the effect of coping on HbA(1c) was only partially mediated by adherence.
CONCLUSION: Coping with diabetes-related issues is an important factor in both types of diabetes, with type 1 patients showing slightly stronger associations. Therefore, training and education programs for diabetic adults might benefit from including a component that is aimed at improving coping with issues specific to diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149598

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

Review 1.  Patient-reported assessments in diabetes care: clinical and research applications.

Authors:  Soren E Skovlund
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

2.  Health-Related Quality of Life, Subjective Health Complaints, Psychological Distress and Coping in Pakistani Immigrant Women With and Without the Metabolic Syndrome : The InnvaDiab-DEPLAN Study on Pakistani Immigrant Women Living in Oslo, Norway.

Authors:  Victoria Telle Hjellset; Camilla M Ihlebæk; Benedikte Bjørge; Hege R Eriksen; Arne T Høstmark
Journal:  J Immigr Minor Health       Date:  2011-08

3.  Validation of the Adherence Barriers Questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence.

Authors:  Sabrina Müller; Thomas Kohlmann; Thomas Wilke
Journal:  BMC Health Serv Res       Date:  2015-04-10       Impact factor: 2.655

4.  Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis.

Authors:  Janie Houle; François Lauzier-Jobin; Marie-Dominique Beaulieu; Sophie Meunier; Simon Coulombe; José Côté; François Lespérance; Jean-Louis Chiasson; Louis Bherer; Jean Lambert
Journal:  BMJ Open Diabetes Res Care       Date:  2016-05-11

5.  Rethinking retention: Mapping interactions between multiple factors that influence long-term engagement in HIV care.

Authors:  Stephanie M Topp; Chanda Mwamba; Anjali Sharma; Njekwa Mukamba; Laura K Beres; Elvin Geng; Charles B Holmes; Izukanji Sikazwe
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

6.  Improvement of primary health care of patients with poorly regulated diabetes mellitus type 2 using shared decision-making--the DEBATE trial.

Authors:  Eva Drewelow; Anja Wollny; Michael Pentzek; Janine Immecke; Sarah Lambrecht; Stefan Wilm; Iris Schluckebier; Susanne Löscher; Karl Wegscheider; Attila Altiner
Journal:  BMC Fam Pract       Date:  2012-08-22       Impact factor: 2.497

Review 7.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.